Nitrosamine Impurities Testing

Nitrosamine Impurities Testing
Product Description

SGS Life Sciences has considerable expertise in the method development of nitrosamine determination in pharmaceutical products. SGS has established a specific method for NDMA which can be applied to various different matrices. Alternatively, a platform method, based on trace-level detection by LC-MSMS, is also available and provides rapid and simultaneous determination of up to ten different, targeted nitrosamines. Although with more limited application, the SGS network is also able to support specialist methodologies such as GC-MSMS. Our experience in optimizing extraction procedures allows application of these methods to drug products, API’s, and raw materials. 

SGS Group Management SA

  • CH
  • 2020
    On CPHI since
Company types
Other
Specifications
  • Supplied from
    Switzerland; United States

SGS Group Management SA

  • CH
  • 2020
    On CPHI since
Company types
Other

More Products from SGS Group Management SA (4)

  • Extractables & Leachables

    Product Extractables & Leachables

    Extractables & leachables studies enable drug sponsors to quantify and identify the risks of potentially toxic leachable impurities migrating into a drug solution from container closure systems, processing equipment or packaging. Regulatory bodies such as the US Food and Drug Administration (FDA) and The ...
  • Quality Control Testing

    Product Quality Control Testing

    Bringing a compound from the laboratory to the market is a long and winding road with a great number of scientific, safety and regulatory challenges. SGS has been offering high quality analytical testing and clinical research services to support drug research, registration and production. 
    SGS leverag...
  • Biosafety Testing

    Product Biosafety Testing

    Life-saving medicines are heavily regulated during development, manufacture and distribution. To fulfill regulatory requirements, the biopharmaceutical industry is increasingly looking for independent service providers who can deliver comprehensive characterization solutions on one site. 
    SGS’s global...
  • Viral Safety Testing

    Product Viral Safety Testing

    SGS’s global center of excellence for cell bank characterization & virus testing is located in the United Kingdom and provides services with ultimate reliability, highest GLP/cGMP quality & scientific expertise.

    For any of your biologics, we help you comply with the global regulator...

SGS Group Management SA resources (3)

  • News SGS Joins Oxford University Consortium Led by the Jenner Institute to Develop COVID-19 Vaccine

    In a consortium led by the Jenner Institute, Oxford University, SGS has joined forces with specialists in infectious diseases, research and innovation, and pharmaceuticals to rapidly develop, scale-up and produce a potential vaccine called ChAdOx1 nCov-19
  • Brochure Analytical Testing and Quality Control Solutions

    Bringing a compound from the laboratory to the market is a long and winding road with a great number of scientific, safety and regulatory challenges. SGS has been offering high quality analytical testing and clinical research services to support drug research, registration and production. 
    SGS leverages its conveniently located network of laboratories and clinical trial facilities present in North America, Europe and Asia-Pacific, to deliver harmonized solutions to large pharmaceutical and biotechnology firms. 
    Our experts provide effective and efficient testing solutions for analytical development, biologics characterization, biosafety and quality control, as well as clinical research services. We perform a variety of tests that are bespoke, client-specific and support the full clinical development, from Phase I First-in-Human trials in our Clinical Pharmacology Units to Phase II and Phase III studies in patients.
  • Video VIDEO: SGS vs COVID-19: Biologics Characterization Services

    SGS' integrated network of laboratories provides a wide range of essential services to support the fight against COVID-19. We provide established expertise and resources for all aspects of biopharmaceuticals characterization, from physico-chemical properties, to primary, secondary, and tertiary structures, as well as aggregation.
    For more information, contact [email protected] or visit: https://www.sgs.com/lifescience.